Want to join the conversation?
$THC 2Q15 PR: Net operating revenues, after the provision for doubtful accounts, grew by $454MM, or 11.2%, to $4.492Bil vs. $4.038Bil in 2Q14. Including continuing and discontinued operations, reported net loss attributable to common shareholders of $61MM after-tax, or $0.61 per share vs. $26MM after-tax, or $0.27 per share in 2Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?